In this context it is unsurprising that expression of other regulator of EGFR endocytosis, such as Rab5, are markers of poor prognosis [58] and lymph node metastasis in breast cancers [59]. Here, EGFR is linked to metastatic malignant neoplasm in the lymph nodes.